Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren vs Placebo and Losartan in Mild to Moderate Essential Hypertension
NCT00344110Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2006
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aliskiren in essential hypertension, sponsored by Novartis. Started Jun 2006; status: completed.
02
Drugs
aliskiren
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00344110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00344110.